Literature DB >> 30943750

Idiopathic Granulomatous Mastitis - a new approach in diagnostics and treatment.

L Vanovcanova1,2, V Lehotska1,2, K Machalekova3, I Waczulikova4, E Minarikova5, K Rauova1,2, K Kajo3,6.   

Abstract

Idiopathic granulomatous mastitis (IGM) is a rare inflammatory breast disease mimicking carcinoma and puerperal or non-puerperal mastitis. The primary purpose of this prospectively performed case control study was to compare clinical and imaging signs of IGM with the reference group of nonspecific, non- puerperal mastitis (NM) to identify the most typical clinical and imaging signs essential for a correct differential diagnosis. The secondary purpose was to present a new approach to non-invasive treatment. Thirty-nine women with histologically proven IGM and twenty-six patients with nonspecific mastitis underwent clinical examination, breast ultrasound (US), mammography (MG) and MRI examination. The most typical signs were selected for each group, and method and were statistically evaluated. The effectivity of colchicine, vitamin E and ribwort plantain tincture in treatment was assessed by clinical examination and imaging. Typical clinical signs of IGM included unilateral acute onset of breast edema, redness, palpable masses, missing fever, lymphadenopathy, no response to antibiotics or surgical interventions. Ultrasound revealed: "finger-like" structures (100%), ductectasias (76.9%), abscesses (76.9%), and lymphadenopathy (15.4%), while in MRI skin and tissue edema (100%), multicentric lesions (100%), abscesses (76.9%), ring enhancement (84.6%), lymphadenopathy (15.4%) and small enhancing lymph nodes (38.5%) were observed. Among the clinical signs, fistulas, hypoechoic mass, ductectasias and diffusion weighted images (DWI) restriction were significantly more frequent in patients with IGM than in those with NM. Treatment effectivity yielded 100% with a complete response between 6-19 months, depending on the disease extent. Targeted questions together with imaging can speed up selection for proper treatment with colchicine, vitamin E and local treatment. Long lasting use of antibiotics and repeated surgical interventions should be avoided.

Entities:  

Mesh:

Year:  2019        PMID: 30943750     DOI: 10.4149/neo_2019_190201N100

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  3 in total

1.  You'll see it when you know it: granulomatous mastitis.

Authors:  Elana Smith; Dan A Moore; Sheryl G Jordan
Journal:  Emerg Radiol       Date:  2021-07-22

2.  Comment on ‘Treatment of idiopathic granulomatous mastitis and factors related with disease recurrence’

Authors:  Emre Tekgöz; Seda Çolak; Muhammet Çinar; Sedat Yilmaz
Journal:  Turk J Med Sci       Date:  2020-12-17       Impact factor: 0.973

Review 3.  Idiopathic Granulomatous Mastitis Presenting in a Patient With Hypothyroidism and Recent Hospitalization for Myxedema Coma: A Rare Case Report and Review of Literature.

Authors:  Stephen Bell; Ricardo Villasmil; Natalia Lattanzio; Qassem Abdelal; Alan King; Vida Farhangi
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.